Segmentectomy Could Be Alternative to Lobectomy in Early NSCLC
Segmentectomy represents a viable alternative to lobectomy for patients with early non-small cell lung cancer, while wedge resection is less favorable.
Read More
Search Physician’s Weekly
Search for articles, editorials, meeting coverage, podcasts, and more
Showing 1 - 20 of 1149 results for 'NSCLC'
Capmatinib Effective with Manageable Safety in METex14 NSCLC, Including Brain Metastases
The following is a summary of “Capmatinib efficacy for METex14 non-small cell lung cancer...
Read More
Long-Term Risk of Rib Fractures Following SBRT for Localized NSCLC
The following is a summary of “Cumulative rib fracture risk after stereotactic body radiotherapy...
Read More
Comparable Postoperative Outcomes in NSCLC Surgery: Survival Influenced by Comorbidities and Nutritional Status, Not Age
The following is a summary of “Peri- and postoperative morbidity and mortality in older patients...
Read More
Physical Performance Predicts Survival in NSCLC
New findings suggest physical performance may be a key prognostic factor for overall survival in patients with metastatic non-small cell lung cancer.
Read More
AI Detects EGFR Mutations in NSCLC With Brain Metastases
An AI model was able to outperform a radiomics model in detecting epidermal growth factor receptor gene mutation in patients with NSCLC and brain metastasis.
Read MoreBenefits of Involving Pharmacists in NSCLC Care
Physician’s Weekly (PW) spoke with Yvette C. Terrie, BS Pharm, RPh, consultant pharmacist, to gain insight into why pharmacists are a crucial part of the care team for patients with non-small-cell lung cancer (NSCLC). PW: What...
Read More
Test More of Your Knowledge of eNSCLC From ASCO 2024!
Do you remember the eNSCLC research presented at ASCO 2024? Test more of your knowledge with new questions and see how you rank!
Read More
The Important Role of a Pharmacist in Treating Patients With NSCLC
Yvette C. Terrie, BS Pharm, RPh, consultant pharmacist, explains why pharmacists are a crucial part of the care team for patients with NSCLC.
Read MoreAdvertisement
Test Your Knowledge of eNSCLC Presented at ASCO 2024!
Do you remember the eNSCLC research presented at ASCO 2024? Test your knowledge now and see how you rank!
Read More
Sotorasib vs. Docetaxel in Advanced NSCLC: Lower Symptom Severity and Better QoL with Sotorasib
The following is a summary of “Patient-reported outcomes in CodeBreak 200: Sotorasib versus...
Read More
ASCO 2024 eBook on eNSCLC
A curated eBook featuring ASCO 2024 eNSCLC-focused studies, findings, and expert opinions.
Read More
TKI With or Without SRS for Brain Metastases From EGFR/ALK Mutated NSCLC
1. Median overall survival was 41 months in the TKI-only group vs 40 months in the TKI-SRS group,...
Read More
CME/CE: Stereotactic Ablative Radiotherapy Safe for Unresectable NSCLC With ILD
This course discusses the safety of stereotactic ablative radiotherapy in patients with early...
Read More
Pulmonologists’ Perceptions of Their Roles in Biomarker Testing for NSCLC
The following is a summary of “Pulmonologists’ Attitudes and Role in Precision Medicine Biomarker...
Read More
Retrospective Study of Treatment Patterns and Survival in Early-Stage NSCLC Post-Resection
The following is a summary of “A retrospective analysis of treatment patterns, overall survival,...
Read More
Why Do Physicians Order NSCLC Biomarker Tests, and Who Gets Appropriate Targeted Therapy?
Biomarker tests for non-small lung cancer (NSCLC) improve patient outcomes, but they are not available to everyone.
Read More
EGCG Regulates Ferroptosis by Downregulating tsRNA-13502 in NSCLC
The following is a summary of “Epigallocatechin gallate modulates ferroptosis through...
Read More
Molecular Testing Appears To Be Increasing in eNSCLC
An increasing number of patients with eNSCLC currently have access to biomarker testing and targeted therapies, according to the MYLUNG consortium.
Read More
#VisualAbstract: Amivantamab plus Lazertinib Improves Outcomes in Previously Untreated EGFR-Mutated Advanced NSCLC
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read More